In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Related
Latest
Wakefern taps iA to implement central fill pharmacy system
“We’re proud to partner with Wakefern as they advance their ShopRite Pharmacy operations through a centralized fulfillment model,” said Tom Utech, iA CEO.
Nestlé sells half of water business to Platinum Equity
The Peranel joint venture will include Perrier and S. Pellegrino and is valued at approximately $5.6 billion.
McCormick plans four divisions after Unilever Foods deal
The company will organize its operations into Americas Consumer, International Consumer, Global Food Service and Global Flavor.
RLC defends refrigeration compliance deadlines for retailers
The associations aim to defend the rule’s extended deadlines for supermarkets, grocers, and food-industry businesses to transition to compliant refrigeration.